Covered recipient · General Payments record
DEMETRIUS S MAOURY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,383.47
- Reported across 215 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $467.44 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $203.15 | 11 |
| Novo Nordisk AS | $114.35 | 7 |
| Astellas Pharma US Inc | $46.43 | 2 |
| PFIZER INC. | $39.84 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.42 | 1 |
| Acerta Pharma LLC | $16.56 | 1 |
| Phathom Pharmaceuticals, Inc. | $14.48 | 1 |
| Amgen Inc. | $13.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.77 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962082 | CMS |
| ABBVIE INC. | $18.11 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962084 | CMS |
| ABBVIE INC. | $30.69 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962086 | CMS |
| ABBVIE INC. | $20.96 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962088 | CMS |
| ABBVIE INC. | $13.02 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962090 | CMS |
| ABBVIE INC. | $26.26 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962092 | CMS |
| ABBVIE INC. | $19.03 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962094 | CMS |
| ABBVIE INC. | $13.79 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962096 | CMS |
| ABBVIE INC. | $10.26 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962098 | CMS |
| ABBVIE INC. | $10.32 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962100 | CMS |
| ABBVIE INC. | $21.94 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104962102 | CMS |
| Amgen Inc. | $13.21 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117318532 | CMS |
| Astellas Pharma US Inc | $23.64 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139398717 | CMS |
| Astellas Pharma US Inc | $22.79 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139446290 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.56 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104478416 | CMS |
| Novartis Pharmaceuticals Corporation | $19.42 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087099936 | CMS |
| Novo Nordisk Inc | $17.56 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097585773 | CMS |
| Novo Nordisk Inc | $16.04 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096572898 | CMS |
| Novo Nordisk Inc | $14.17 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096800031 | CMS |
| Novo Nordisk Inc | $16.41 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097171023 | CMS |
| Novo Nordisk Inc | $16.99 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097475715 | CMS |
| Novo Nordisk Inc | $16.77 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096610934 | CMS |
| Novo Nordisk Inc | $16.41 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097430317 | CMS |
| PFIZER INC. | $15.79 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131755828 | CMS |
| PFIZER INC. | $24.05 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131281412 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.48 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151092919 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.